|
Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma |
|
|
|
Titel: |
Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma |
Auteur: |
Hagege, Anais Saada-Bouzid, Esma Ambrosetti, Damien Rastoin, Olivia Boyer, Julien He, Xingkang Rousset, Julie Montemagno, Christopher Doyen, Jérome Pedeutour, Florence Parola, Julien Bourget, Isabelle Luciano, Frederic Bozec, Alexandre Cao, Yihai Pagès, Gilles Dufies, Maeva |
Verschenen in: |
Cell reports medicine |
Paginering: |
Jaargang 3 () nr. 9 pagina's p. |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
CNRS |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|